BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Artificial intelligence
Biosimilars
China CAR T
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Monday, May 13, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
April 27, 2009
View Archived Issues
Kowa claims novel G-protein-coupled receptor 40 and 120 agonists as antidiabetic agents
Read More
Novel vanilloid receptor ligands for the treatment of pain disclosed by Amgen
Read More
NeuroSearch presents novel potassium channel modulators for the treatment of respiratory disorders
Read More
GlaxoSmithKline claims novel compounds for the treatment of anemia
Read More
Amgen presents p38 protein kinase inhibitors for the treatment of rheumatoid arthritis
Read More
Second-generation FLT3 inhibitor developed as a candidate for acute myeloid leukemia therapy
Read More
Preclinical studies of ARRY-520 aid in selecting target cancers
Read More
Ajinomoto and Dainippon granted approval for additional indication for Niflec and Gasmotin
Read More
AcelRx initiates phase II cancer breakthrough pain program
Read More
First-in-man results with IDX-84, data on other HCV treatments from Idenix presented
Read More
OPERA-1 interim results show potent antiviral activity of TMC-435 against hepatitis C
Read More
Perlegen and Celera sign license agreement for cardiovascular biomarkers
Read More
CHMP issues positive opinion for AstraZeneca's oral anticancer drug, Iressa
Read More
FDA approves IND for ConjuGon's phase Ib C-1205 trial
Read More
Zoledronic acid may reduce androgen-deprivation-induced bone loss in prostate cancer patients
Read More
FDA extends review timeline for Onglyza NDA
Read More
Promising preclinical results seen with new HCV protease inhibitors EA-058, EA-063
Read More
Genesis changes name to Jiangbo Pharmaceuticals
Read More
Selective inhibitors of anaplastic lymphoma kinase show in vitro and in vivo antitumor activity
Read More
Novo Nordisk receives positive CHMP opinion on Victoza
Read More
Nycomed's Instanyl receives positive CHMP opinion for cancer pain
Read More
Targacept initiates phase II TC-5214 study in patients with resistant hypertension
Read More
Pfizer and University College London to collaborate on stem cell-based therapies for AMD
Read More
Health Canada approves Cangene's hepatitis B therapeutic HepaGam B for second indication
Read More
Simponi receives FDA approval as once-monthly anti-TNF for RA
Read More
Icagen completes enrollment in phase II study of senicapoc in allergic asthma
Read More